Editas Medicine, Inc.
EDIT
$1.28
$0.010.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 30.60M | 61.00K | 513.00K | 1.14M | 60.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.60M | 61.00K | 513.00K | 1.14M | 60.05M |
| Cost of Revenue | 48.61M | 47.64M | 2.13M | 48.79M | 69.56M |
| Gross Profit | -18.01M | -47.58M | -1.61M | -47.65M | -9.51M |
| SG&A Expenses | 16.35M | 18.09M | 18.21M | 19.34M | 14.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 64.97M | 65.73M | 72.42M | 68.13M | 84.01M |
| Operating Income | -34.36M | -65.67M | -71.90M | -66.99M | -23.96M |
| Income Before Tax | -45.40M | -62.14M | -67.61M | -61.95M | -18.87M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -45.40M | -62.14M | -67.61M | -61.95M | -18.87M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.40M | -62.14M | -67.61M | -61.95M | -18.87M |
| EBIT | -34.36M | -65.67M | -71.90M | -66.99M | -23.96M |
| EBITDA | -32.98M | -64.07M | -70.48M | -65.58M | -22.50M |
| EPS Basic | -0.55 | -0.75 | -0.82 | -0.76 | -0.23 |
| Normalized Basic EPS | -0.25 | -0.47 | -0.51 | -0.47 | -0.13 |
| EPS Diluted | -0.55 | -0.75 | -0.82 | -0.76 | -0.23 |
| Normalized Diluted EPS | -0.25 | -0.47 | -0.51 | -0.47 | -0.13 |
| Average Basic Shares Outstanding | 82.61M | 82.49M | 82.31M | 81.94M | 81.71M |
| Average Diluted Shares Outstanding | 82.61M | 82.49M | 82.31M | 81.94M | 81.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |